Retatrutide (20mg)

Description

Retatrutide (20mg Vial)

Specification: 20mg Retatrutide lyophilized research powder.

Purity: ≥99.0% (HPLC Verified).

Research Overview: Retatrutide is a potent multi-target peptide agonist investigated in metabolic signaling, glucose homeostasis, and weight regulation studies.

Reconstitution & Handling Protocol:

• Reconstitute with 2.0ml Bacteriostatic Water.
• Store reconstituted solution at 2°C – 8°C. Protect from light.

  Retatrutide: A next-generation single-molecule peptide engineered as a GLP-1, GIP, and Glucagon triple-receptor agonist.

  • Primary Benefits: Delivers robust central appetite regulation, suppresses hunger signals, and accelerates basal metabolic rate via glucagon-driven thermogenesis.

  • Secondary / Other Benefits: Directly targets stubborn visceral and hepatic (liver) fat stores, significantly enhances insulin sensitivity, and improves systemic glycemic control.